Honasa stock hits 52-week high as FY31 roadmap targets Rs 5,500 cr revenue, 300K outlets
Mamaearth parent Honasa Consumer rallied 77% in six months to a 52-week high of Rs 438 after Investor Day 2026. FY31 targets: Rs 5,500 cr revenue, 15%+ EBITDA, Mamaearth as a Rs 2,000 cr brand, Derma Co at Rs 1,500 cr+, plus expansion into nutraceuticals, fragrances and oral care. Retail reach to triple from 120K to 300K outlets.
What happened
Honasa Consumer stock hit 52-week high of Rs 438 after Investor Day 2026 unveiled FY31 targets: Rs 5,500 cr revenue, 15%+ EBITDA, Mamaearth as Rs 2,000 cr
Key facts
- 77% rally in 6 months
- 52-week high Rs 438
- FY26 revenue Rs 2,400 cr
- FY26 PAT Rs 200 cr
- FY31 revenue target Rs 5,500 cr
- EBITDA margin target >15%
- Mamaearth FY31 target Rs 2,000 cr+
- Derma Co target Rs 1,500 cr+
- retail reach 120,000 to 300,000 outlets
- market cap Rs 13,814 cr
Why this matters
Honasa's stated push into nutraceuticals, fragrances, and oral care signals a buy-versus-build window—scout small D2C brands in those adjacencies now before Honasa's premium and capital advantage compress acquisition multiples.